Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to support the process development and scale up activities at SK Chemicals for the development of Vi-DT conjugate vaccine to support a large scale immunogenicity clinical trial (P3) and WHO PQ of the vaccine in the 2020-2022 timeframe.
Grantee
Division
Global Health
Date
JUNE 2018
Region Served
GLOBAL
Committed Amount
$4,999,977
Grant Topic
Enteric and Diarrheal Diseases
Duration (Months)
70
Grantee Location
Seoul, Korea, Republic of
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.